BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Center For Technology Licensing - ECPv6.11.2.1//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Center For Technology Licensing
X-ORIGINAL-URL:https://ctl.cornell.edu
X-WR-CALDESC:Events for Center For Technology Licensing
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:UTC
BEGIN:STANDARD
TZOFFSETFROM:+0000
TZOFFSETTO:+0000
TZNAME:UTC
DTSTART:20190101T000000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=UTC:20230223T100000
DTEND;TZID=UTC:20230223T173000
DTSTAMP:20260530T150247
CREATED:20230131T024939Z
LAST-MODIFIED:20230131T025009Z
UID:10000338-1677146400-1677173400@ctl.cornell.edu
SUMMARY:2023 Weill Cornell Medicine Startup Symposium & InvestConnect Conference
DESCRIPTION:The 2023 Weill Cornell Medicine Startup Symposium & InvestConnect Conference is a full-day event where faculty founders\, investors\, and ecosystem partners convene to learn more about WCM innovations. \nThe morning program includes panel discussions and presentations directed to startup founders. This year\, the event will feature a fireside chat with a special guest\, Behzad Aghazadeh\, PhD’00\, Managing Partner\, Avoro Capital Advisors. The morning panel discussions and presentations are open to all conference registrants. \nThe afternoon program offers a hybrid forum for WCM founders to hold 1:1 meetings with early-stage investors. The meetings are pre-arranged using a technology platform hosted by BioVenture eLab. Use of the technology platform is by invitation only. \nAll conference registrants are welcome to interact with WCM founders during the Startup Showcase in the afternoon (2-5.30 pm). Startup Showcase will offer a forum for posters and technology demonstrations of WCM innovations. A cocktail reception will take place in the late afternoon (4-5.30 pm). \nThe Startup Symposium & InvestConnect Conference is an anchor program for attracting attention to Weill Cornell’s life science innovations. We look forward to welcoming you to our ecosystem\, be it through on-site or virtual participation. \n*The full benefits of the conference will be realized with on-site participation.* \n  \nEvent agenda can be found here. \nMore information and registration here.
URL:https://ctl.cornell.edu/event/2023-wcm-startup-symposium
LOCATION:Belfer Research Building\, 413 E 69th St\, New York\, NY\, NY\, 10021\, United States
CATEGORIES:Cornell Community Events
ATTACH;FMTTYPE=image/png:https://ctl.cornell.edu/wp-content/uploads/2023/01/WCM-Startup-SymposiumEvents-page-image-size-700x500px.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=UTC:20221114T150000
DTEND;TZID=UTC:20221114T173000
DTSTAMP:20260530T150247
CREATED:20221102T005142Z
LAST-MODIFIED:20221102T005142Z
UID:10000296-1668438000-1668447000@ctl.cornell.edu
SUMMARY:Sixth Annual Symposium on Entrepreneurship and Academic Drug Development
DESCRIPTION:Annual symposium organized by WCM Enterprise Innovation and the Dean’s Office on entrepreneurship and drug and device development. This year’s keynote speaker is George Church\, Professor of Genetics at Harvard Medical School and Massachusetts Institute of Technology. We are also introducing a new feature: pre-symposium workshops on resources for developing novel therapeutics. \n  \nRegister here.
URL:https://ctl.cornell.edu/event/sixth-annual-symposium-on-entrepreneurship-and-academic-drug-development
LOCATION:Belfer Research Building\, 413 E 69th St\, New York\, NY\, NY\, 10021\, United States
CATEGORIES:Cornell Community Events
ATTACH;FMTTYPE=image/png:https://ctl.cornell.edu/wp-content/uploads/2022/11/EI-Events-page-image-size-700x500px.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=UTC:20191120T153000
DTEND;TZID=UTC:20191120T180000
DTSTAMP:20260530T150247
CREATED:20191113T041535Z
LAST-MODIFIED:20191113T041535Z
UID:10000189-1574263800-1574272800@ctl.cornell.edu
SUMMARY:WCM Dean's Third Annual Symposium on  Entrepreneurship and Academic Drug Development
DESCRIPTION:Dean Augustine M.K. Choi proudly presents: Third Annual Symposium on Entrepreneurship and Academic Drug Development \n  \nThis symposium is designed for faculty\, trainees\, and students interested in advancing their research from the lab to the clinic. \nLearn how you can work with the Center for Technology Licensing\, BioPharma Alliances and Research Collaborations\, Tri-Institutional Therapeutics Discovery Institute\, and Bridge Medicines to commercialize your discoveries. \n  \nKeynote Address “Life Science\, From Bench to Bedside” \nThis presentation offers insight into the life sciences industry\, from the perspective of both an academic entrepreneur and an investment banker in the healthcare sector. \n\nArie S. Belldegrun\, MD\n\nDirector\, Institute of Urologic Oncology\, Professor\, Urologic Oncology\, Roy and Carol Doumani Chair in Urologic Oncology\, University of California\, Los Angeles\, Executive Chairman and Co-Founder\, Allogene Therapeutics \n\nAlan Hartman\n\nPartner\, Centerview Partners \n  \nPresentations by WCM faculty: Dr. Rainu Kaushal\, Dr. Jyotishman Pathak and Dr. Carl Nathan \n  \nReception to follow\, 5-6 PM \n  \nLocation: Belfer Research Building\, 413 E. 69th Street\, 302-A/B/C/D \n  \nRSVP: https://weillcornell.az1.qualtrics.com/jfe/form/SV_eLkbCoPeATvBJ9b \n 
URL:https://ctl.cornell.edu/event/wcm-deans-third-annual-symposium-on-entrepreneurship-and-academic-drug-development
LOCATION:Belfer Research Building\, 413 E 69th St\, New York\, NY\, NY\, 10021\, United States
CATEGORIES:Partner Events
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=UTC:20191107T170000
DTEND;TZID=UTC:20191107T180000
DTSTAMP:20260530T150247
CREATED:20191013T014213Z
LAST-MODIFIED:20191013T014213Z
UID:10000182-1573146000-1573149600@ctl.cornell.edu
SUMMARY:CTL Enterprise Seminar - The Nuts and Bolts of University-based Startups
DESCRIPTION:Learn from Wilson Sonsini Goodrich & Rosati (WSGR) about the nuts and bolts of University-based Startups. \nJoin us for an overview and active discussion with deeply experienced professionals from Silicon Valley\, hear their perspective on: \n\nCreating Business Plans\nLicensing University Technologies\nRaising Capital\n\nAgenda: \n5:00 PM – 5:10 PM  Introduction \n5:10 PM – 5:50 PM  Presentation \n5:50 PM – 6:00 PM  Q&A \nAppetizers and drinks will be served. \n  \nKatharine “Kathy” Ku\, Chief Licensing Advisor\, Wilson Sonsini Goodrich & Rosati – Palo Alto office \nKathy served as the Executive Director of Stanford University’s Office of Technology Licensing (OTL) for 27 years. During that period\, OTL licensed out hundreds of new technologies\, bringing in $1.8 billion\, most of which went back to support research and education at Stanford.  Because Stanford’s OTL licensed many start-ups\, including Google\, Tableau\, iRhythm\, she understands the challenges of building a successful company through a robust intellectual property portfolio. \nKathy served as President of the Association of University Technology Managers.   She also spearheaded the development and implementation of nine principles related to university technology licensing. The principles are set forth in document entitled “In the Public Interest: Nine Points to Consider in Licensing University Technology.” More than 120 institutions have adopted the principles since they were published in 2007. \n  \nMatthew J. Meyer\, Chief Client Corporate Development Advisor in the life sciences\, Wilson Sonsini Goodrich & Rosati \nBased in San Francisco\, Matthew leads the firm’s life science business advisory practice—a newly formed\, innovative resource aimed at providing start-up and emerging life sciences companies with business insights\, capabilities\, and strategies to help them thrive and address some of their most challenging issues. \nMatthew is an experienced executive and corporate attorney who has held diverse roles of increasing responsibility across a wide range of private and public biopharma\, medtech\, and precision medicine companies from start-ups to Fortune 50 in the U.S. and Europe\, including Pfizer\, Novartis\, and CareDx. His leadership capabilities include delivery of strong commercial results\, structuring and executing partnering transactions across the product life cycle\, raising debt and equity capital in the private and public markets\, and working with founders\, management teams\, and boards to address complex business issues to support rapid growth. \n  \nFor more information\, please download a summary of the WSGR business advisory practice here. \n  \nVenue: Belfer Research Building\, Room BB 302-C&D\, 413 East 69th St\, New York\, NY 10021 \nRSVP: https://cornell.qualtrics.com/jfe/form/SV_dpqARA2U8oPKyvb \nContact information: Lynda Inseque\, Program Manager\, Technology Initiatives & Outreach\, lci2@cornell.edu \n 
URL:https://ctl.cornell.edu/event/ctl-enterprise-s2
LOCATION:Belfer Research Building\, 413 E 69th St\, New York\, NY\, NY\, 10021\, United States
CATEGORIES:CTL Events
ATTACH;FMTTYPE=:
END:VEVENT
END:VCALENDAR